Indivior CSO Christian Heidbreder disposes of $764,432.04 in common shares
INDV•Chief scientific officer sells shares
- Indivior Pharmaceuticals Chief Scientific Officer Christian Heidbreder sold 18,586 common shares on July 10, 2026 at USD 41.14.
- Heidbreder’s direct holding fell to 209,337 shares following the transaction.
Related News

Avis Budget Group updates financial calendar for upcoming quarterly results and investor call
CAR•

Orchid Island Capital Announces Estimated Second Quarter 2026 Results And June 30, 2026 RMBS Portfolio Characteristics
ORC•


